期刊文献+

胡芦巴碱、五味子油和二甲双胍联合治疗对糖尿病大鼠糖脂代谢和Neuritin表达的影响

Effect of combined treatment of trigonelline, Fructus Schisandrae oil and Metformin on glucose and lipid metabolisms and hippocampal neuritin expression in type 2 diabetic rats
下载PDF
导出
摘要 目的研究探讨胡芦巴碱、五味子油和二甲双胍联合治疗对2型糖尿病大鼠糖脂代谢和海马区Neuritin表达的影响。方法采用链脲佐菌素+高糖、高脂饲料喂养,建立2型糖尿病大鼠模型。糖尿病大鼠分为糖尿病模型组、药物联合治疗和罗格列酮组,每组11只大鼠,连续给药8周。另取10只正常SD大鼠作为正常对照组。检测各组大鼠空腹血糖(FBG),糖化血红蛋白(HbA1c)、空腹血清胰岛素(FINS)、总胆固醇(TC)、三酰甘油(TG)、肝糖原和肌糖原水平,实时聚合酶链反应、Western blot检测分析海马区Neuritin表达水平。结果给药8周后,糖尿病模型组大鼠FBG、HbA1c、FINS、TC、TG升高,胰岛素敏感指数(ISI)、肝糖原和肌糖原水平、海马Neuritin mRNA及蛋白表达水平下降,与正常对照组比较差异有统计学意义(P<0.01)。与糖尿病模型组比较,药物联合治疗组和罗格列酮组大鼠FBG、HbA1c、FINS水平下降,而ISI、肝糖原和肌糖原水平、海马Neuritin mRNA及蛋白表达水平上升,差异有统计学意义(P<0.01);药物联合治疗组与糖尿病模型组比较,TC、TG下降,差异有统计学意义(P<0.01),而与罗格列酮组TC、TG比较,差异无统计学意义(P>0.05)。结论胡芦巴碱、五味子油和二甲双胍联合治疗能改善糖尿病大鼠糖脂代谢和海马区Neuritin表达。 Objective To observe the effect of trigonelline, Fructus Schisandrae oil and Metformin therapy on neuritin expression in hippocampal area and glucose and lipid metabolisms in rats with type 2 diabetes. Methods Type 2 diabetic rat model was established by feeding Streptozotocin plus high-sugar and high-lipid diet. The diabetic rats were divided into diabetic model group, combined drug treatment group and Rosiglitazone group with 11 rats in each group. The rats received continuous treatment for 8 weeks. The normal control group consisted of 10 normal SD rats. FBG, HbAlc, TC, FINS, TG, liver glycogen and muscle glycogen levels were tested. Real-time PCR and Western blot were used to determine neuritin expression level in hippocampus. Results Compared with the normal control group, the FBG, HbAlc, FINS, TC and TG levels were increased significantly; the insulin sensitivity index (ISI), liver glycogen and muscle glycogen levels, hippocampal neuritin mRNA and protein expressions were decreased significantly in the diabetic model group after treatment for 8 weeks (P〈0.01). Compared with the diabetic model group, the FBG, HbA1c and FINS levels were significantly decreased; but ISI, liver glycogen and muscle glycogen levels, and the expression levels of hippocampal neuritin mRNA and protein were significantly increased in the combined drug treatment group and Rosiglitazone group (P〈 0.01). Compared with the diabetic model group, TC and TG decreased significant- ly in the combined drug treatment group (P〈 0.01); but there were no significant differences in TC or TG between the diabetic model group and the Rosiglitazone group (P 〉 0.05). Conclusions Combined trigonelline, Fructus Schisandrae oil and Mefformin therapy can improve glucose and lipid metabolisms and expression of neuritin in the hippocampus of type 2 diabetic rats.
出处 《中国现代医学杂志》 CAS 北大核心 2016年第11期24-28,共5页 China Journal of Modern Medicine
关键词 胡芦巴碱 五味子油 2型糖尿病 糖脂代谢 海马Neuritin trigonelline Fructus Schisandrae oil type 2 diabetes glucose and lipid metabolisms hippocampal neuritin
  • 相关文献

参考文献15

  • 1SCULLY T. Diabetes in numbers[J]. Nature, 2012, 485: 2-3.
  • 2FUJINO T, LEE W C, NEDIVI E. Regulation of cpgl5 by sig- naling pathways that mediate synaptic plasticity[J]. Mol Cell Neu- rosei, 2003, 24(3): 538-554.
  • 3NOLAN C J, PETER D, PRENTKI M. Type 2 diabetes across generations: from pathophysiology to prevention and management[J]. Lancet, 2011, 378(9786): 169-181.
  • 4ZHOU J, CHAN L, ZHOU S. Trigonelline: a plant alkaloid with therapeutic potential for diabetes andnervous system disease[J]. Curr Med Chem, 2012, 19(21): 3523-3531.
  • 5JIANG M J, MO Z X, ZHOU J Y, et al. Effects of trigonelline on glueolipid metabolization and neuritin expression in hippoeampusof diabetic rats[J]. Chin J New Drubs Clin Rein, 2013, 57(1): 181-189.
  • 6MARZOUK M, SOLIMAN A M, OMAN T Y, et al. Hypoglycemic and antioxidative effects of fenugreek and termis seeds powder in streptozotocin-diabetic rats[J]. Eur Rev Med Pharmacol Sci, 2013, 17(4): 559-565.
  • 7CHATURVEDI U, SHRIVASTAVA A, BHADAURIA S, et al. A mechanism based pharmacological evaluation of efficacy of Trigonella foenom graecum (fenugreek) seeds in regulation of dyslipidemia and oxidative stress in hyperlipidemic rats[J]. J Car- diovasc Pharmacol, 2013, 61(6): DOI: 10.1097/FJC.ObO13e31828b 7822.
  • 8DESHMUKH V S, MOTGHARE V M, PADWAL S L, et al. New- er drugs in the management of diabetes mellitus[J]. Int J Basic Clin Pharmacol, 2013, 2(1): 4-11.
  • 9赵晓南.初发2型糖尿病行磷酸西格列汀联合二甲双胍治疗的疗效分析[J].中国社区医师,2015,31(6):25-25. 被引量:5
  • 10张秀芳,杨秀红,董陆玲.磷酸西格列汀联合二甲双胍治疗新诊断2型糖尿病临床观察[J].河北医药,2014,36(18):2785-2787. 被引量:28

二级参考文献16

  • 1Lehy JL. Pathogenesis of Type 2 diabetesmellitus. Arch Med Res, 2005, 36 : 197-209.
  • 2Azuma K, Radikova Z, Maneino J, et al. Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vilda-gliptin in patients with type 2 diabetes. J Chin Endocrinol Metab,2008, 93:459-464.
  • 3Bosehmann M, Engeli S, Dobberstein K, et al. Dipeptidyl-peptidase-I V inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. Clin Endocrinol Metab ,2009,94:846-852.
  • 4Ivanon KP,Mychka VB. Perspectives of impaired glucose tolerance man- agement in patients with metabolic syndrome. Cardiovase Ther Preven- tion,2011,10:77-82.
  • 5Van Poppel PC, Netea MG ,Smits P ,et al. ViIdagliptin improves endothe- lium-dependent vasodilatationin type 2 diabetes. Diabetes Care, 2011, 34 : 2072 -2077.
  • 6Ahren B. Emerging dipeptidyl peptidnse-4 inhibitors for the treatment of diabetes. Emerging Drugs ,2008,13 : 593-607.
  • 7Nauck M, Meininger G, Sheng D,et al. Efficacy and u f the safety of the dipep tidyl peptidaae-4 inhibitor, sitagliptin, compared to the sulphony- hrea in patients with type 2 diabetes in adequately controlled on met- formin alone : a randomized double-blind, non--infedofity trial. Diabetes Obes-Metah ,2007,9 : 194-205.
  • 8宁光.肠促胰素在血糖稳态调节和2型糖尿病治疗中的作用[J].中华内分泌代谢杂志,2010,26(9):836-839. 被引量:24
  • 9杨光,李春霖,田慧,汪寅章,宗文漪,邵迎红,李剑,黄军华,龚燕平,刘敏燕,闫双通.非肥胖老年2型糖尿病患者使用二甲双胍的疗效及安全性[J].中华老年多器官疾病杂志,2010,9(5):417-420. 被引量:10
  • 10付鸿玉,唐海燕,金雪花.磷酸西格列汀治疗2型糖尿病40例临床观察[J].当代医学,2011,17(16):136-137. 被引量:21

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部